Molecular cartography of initiating and infiltrating glioma cells using multisector sampling and spatial transcriptomics
Active Grant Awarded
- Award ID
- R21NS142788
- Recipient
-
The Translational Genomics Research Institute UEI J19ZXYATJLT3
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $305,960
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date 30% complete
- Place of performance
- Phoenix, AZ 85004, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services' National Institutes of Health, through the National Institute of Neurological Disorders and Stroke, awarded a $305,960 grant to The Translational Genomics Research Institute, doing business as Tgen Research Institute, on April 13, 2026, under Assistance Listing 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders. The award funds molecular cartography of initiating and infiltrating glioma cells using spatial transcriptomics.
Under Aim 1, the recipient will perform spatial transcriptomics on 254 image-mapped samples from 22 distinct tumors, evaluating tumor-microenvironment interactions for each patient and by comparing locations across patients. Under Aim 2, it will build an agent-based model from 179 samples across 20 individuals, integrating imaging, DNA methylation, and DNA sequencing data to reconstruct historical tumor development and forecast future development in space and time. The stated output is a four-dimensional model of tumor cell dissemination that identifies ancestral stem-like tumor cell populations and sites of diffuse infiltration, intended to enable individualized local treatment planning and prognostication.
The period of performance runs from the April 13, 2026 award date to an ultimate completion date of March 31, 2028. Place of performance is Phoenix, Arizona 85004.
Description
- Abstract
- Diffuse dissemination of tumor cells into the brain is one of the key problems impacting optimal treatment of gliomas. We hypothesize that distinct types of tumor cells harbor characteristic diffusion patterns. Specifically, we suspect that NPC-like cells predominate in the cortical layers and interact with the laminar extension of neuronal cells in the cortex, while OPC-like cells dominate subcortically and associate with axons and APC-like cells associate with vascular and immune cells. In order to provide four-dimensional reconstructions of tumor development and test our hypotheses, we will perform spatial transcriptomics on N = 254 image-mapped samples from N = 22 distinct tumors (aim 1). Tumor-microenvironment interactions will be evaluated separately for each patient and by comparing distinct locations across patients. Finally, we will develop an agent-based model using N = 179 samples from N = 20 individual with integrated imaging, DNA methylation and DNA sequencing information to reconstruct historical and forecast future tumor development in space and time (aim 2). The findings of these studies will allow for a high-resolution dissection of the identity and location of ancestral stem- like tumor cell populations, as well as the identification of sites of diffuse infiltration. A four-dimensional model of tumor cell dissemination will enable individualized local treatment planning and prognostication.
Quick answers
Who received award R21NS142788?
R21NS142788 was awarded to The Translational Genomics Research Institute by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on April 13, 2026.
How much is award R21NS142788 worth?
$305,960 has been obligated on R21NS142788.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award